In conclusion, our study identifies Wisp1 as a circulating protein that is abundant in young blood and induces proliferation of adult beta cells, thus revealing Wisp1 as an agent with potential therapeutic use to expand beta cell mass in diabetes. Here, CCN4 is linked to diabetes mellitus.